Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ICI 204448 is a κ-opioid receptor agonist.1 It binds to the κ-opioid receptor (Ki = 2.69 nM) and is 162- and 69-fold selective for the κ-opioid receptor over the μ- and δ-opioid receptors in membranes prepared from cells expressing the human κ-, μ- and δ-opioid receptors, repectively. ICI 204448 reduces acetic acid-induced writhing and chloroquine-induced scratching in mice.1,2 It also reduces infarct size in rat hearts when administered ten minutes prior to the onset of ischemia.3
WARNING This product is not for human or veterinary use.
1. Synthesis and evaluation of novel peripherally restricted κ-
2. Kappa opioid agonists suppress chloroquine-
3. Effect of exogenous kappa-